Naoto Imamachi
University of Tokyo
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Naoto Imamachi.
Molecular Cell | 2014
Katsutoshi Imamura; Naoto Imamachi; Gen Akizuki; Michiko Kumakura; Atsushi Kawaguchi; Kyosuke Nagata; Akihisa Kato; Yasushi Kawaguchi; Hiroki Sato; Misako Yoneda; Chieko Kai; Tetsushi Yada; Yutaka Suzuki; Toshimichi Yamada; Takeaki Ozawa; Kiyomi Kaneki; Tsuyoshi Inoue; Mika Kobayashi; Tatsuhiko Kodama; Youichiro Wada; Kazuhisa Sekimizu; Nobuyoshi Akimitsu
Although thousands of long noncoding RNAs (lncRNAs) are localized in the nucleus, only a few dozen have been functionally characterized. Here we show that nuclear enriched abundant transcript 1 (NEAT1), an essential lncRNA for the formation of nuclear body paraspeckles, is induced by influenza virus and herpes simplex virus infection as well as by Toll-like receptor3-p38 pathway-triggered poly I:C stimulation, resulting in excess formation of paraspeckles. We found that NEAT1 facilitates the expression of antiviral genes including cytokines such as interleukin-8 (IL8). We found that splicing factor proline/glutamine-rich (SFPQ), a NEAT1-binding paraspeckle protein, is a repressor of IL8 transcription, and that NEAT1 induction relocates SFPQ from the IL8 promoter to the paraspeckles, leading to transcriptional activation of IL8. Together, our data show that NEAT1 plays an important role in the innate immune response through the transcriptional regulation of antiviral genes by the stimulus-responsive cooperative action of NEAT1 and SFPQ.
RNA Biology | 2012
Hidenori Tani; Naoto Imamachi; Kazi Abdus Salam; Rena Mizutani; Kenichi Ijiri; Takuma Irie; Tetsushi Yada; Yutaka Suzuki; Nobuyoshi Akimitsu
UPF1 eliminates aberrant mRNAs harboring premature termination codons, and regulates the steady-state levels of normal physiological mRNAs. Although genome-wide studies of UPF1 targets performed, previous studies did not distinguish indirect UPF1 targets because they could not determine UPF1-dependent altered RNA stabilities. Here, we measured the decay rates of the whole transcriptome in UPF1-depleted HeLa cells using BRIC-seq, an inhibitor-free method for directly measuring RNA stability. We determined the half-lives and expression levels of 9,229 transcripts. An amount of 785 transcripts were stabilized in UPF1-depleted cells. Among these, the expression levels of 76 transcripts were increased, but those of the other 709 transcripts were not altered. RNA immunoprecipitation showed UPF1 bound to the stabilized transcripts, suggesting that UPF1 directly degrades the 709 transcripts. Many UPF1 targets in this study were newly identified. This study clearly demonstrates that direct determination of RNA stability is a powerful approach for identifying targets of RNA degradation factors.
BMC Genomics | 2015
Sho Maekawa; Naoto Imamachi; Takuma Irie; Hidenori Tani; Kyoko Matsumoto; Rena Mizutani; Katsutoshi Imamura; Miho Kakeda; Tetsushi Yada; Sumio Sugano; Yutaka Suzuki; Nobuyoshi Akimitsu
BackgroundHistone epigenome data determined by chromatin immunoprecipitation sequencing (ChIP-seq) is used in identifying transcript regions and estimating expression levels. However, this estimation does not always correlate with eventual RNA expression levels measured by RNA sequencing (RNA-seq). Part of the inconsistency may arise from the variance in RNA stability, where the transcripts that are more or less abundant than predicted RNA expression from histone epigenome data are inferred to be more or less stable. However, there is little systematic analysis to validate this assumption. Here, we used stability data of whole transcriptome measured by 5′-bromouridine immunoprecipitation chase sequencing (BRIC-seq), which enabled us to determine the half-lives of whole transcripts including lincRNAs, and we integrated BRIC-seq with ChIP-seq to achieve better estimation of the eventual transcript levels and to understand the importance of post-transcriptional regulation that determine the eventual transcript levels.ResultsWe identified discrepancies between the RNA abundance estimated by ChIP-seq and measured RNA expression from RNA-seq; for number of genes and estimated that the expression level of 865 genes was controlled at the level of RNA stability in HeLa cells. ENCODE data analysis supported the idea that RNA stability control aids to determine transcript levels in multiple cell types. We identified UPF1, EXOSC5 and STAU1, well-studied RNA degradation factors, as controlling factors for 8% of cases. Computational simulations reasonably explained the changes of eventual mRNA levels attributable to the changes in the rates of mRNA half-lives. In addition, we propose a feedback circuit that includes the regulated degradation of mRNAs encoding transcription factors to maintain the steady state level of RNA abundance. Intriguingly, these regulatory mechanisms were distinct between mRNAs and lincRNAs.ConclusionsIntegrative analysis of ChIP-seq, RNA-seq and our BRIC-seq showed that transcriptional regulation and RNA degradation are independently regulated. In addition, RNA stability is an important determinant of eventual transcript levels. RNA binding proteins, such as UPF1, STAU1 and EXOSC5 may play active roles in such controls.
Oncogene | 2016
Rena Mizutani; Naoto Imamachi; Yutaka Suzuki; Hiroshi Yoshida; Naobumi Tochigi; Tadahiro Oonishi; Nobuyoshi Akimitsu
RNA-binding proteins (RBPs) have important roles in tumorigenesis. Although IGF2BP3, an evolutionally conserved RBP, has been reported as a useful diagnostic marker for various cancers and has been considered a regulator of tumorigenesis, little is known of the function of IGF2BP3 because of lack of information regarding IGF2BP3 target mRNAs. Here, we report the identification of IGF2BP3 target mRNAs and IGF2BP3 function in cancer proliferation. We identified mRNAs with altered expression in IGF2BP3-depleted cells by massive sequencing analysis and IGF2BP3-binding RNAs by immunoprecipitation of IGF2BP3 followed by massive sequencing analysis, resulting in the identification of 110 candidates that are negatively regulated by IGF2BP3. We found that IGF2BP3 destabilized EIF4E-BP2 and MEIS3 mRNAs. Co-immunoprecipitation analysis revealed the interaction between IGF2BP3 and ribonucleases such as XRN2 and exosome component. The retarded proliferation of IGF2BP3-depleted cells was partially rescued by the depletion of EIF4E-BP2, which negatively regulates eukaryotic translation initiation factor 4E (eIF4E), an activator of translation and a well-known proto-oncogene. Consistent with this observation, IGF2BP3 depletion reduced phosphorylated eIF4E, the active form, and translational efficiency of eIF4E target transcripts. Reduction of phosphorylated eIF4E by IGF2BP3 depletion was rescued by EIF4E-BP2 depletion. At last, we found an inverse correlation between the expression level of IGF2BP3 and EIF4E-BP2 in human lung adenocarcinoma tissues. Together, these results suggest that IGF2BP3 promotes eIF4E-mediated translational activation through the reduction of EIF4E-BP2 via mRNA degradation, leading to enhanced cell proliferation. This is the first report demonstrating that IGF2BP3 is an RNA-destabilizing factor. Notably, here we provide the first evidence for the functional linkage between two previously well-known cancer biomarkers, IGF2BP3 and eIF4E.
The EMBO Journal | 2018
Katsutoshi Imamura; Akiko Takaya; Yo-ichi Ishida; Yayoi Fukuoka; Toshiki Taya; Ryo Nakaki; Miho Kakeda; Naoto Imamachi; Aiko Sato; Toshimichi Yamada; Rena Onoguchi-Mizutani; Gen Akizuki; Tanzina Tanu; Kazuyuki Tao; Sotaro Miyao; Yutaka Suzuki; Masami Nagahama; Tomoko Yamamoto; Torben Heick Jensen; Nobuyoshi Akimitsu
Cytoplasmic mRNA degradation controls gene expression to help eliminate pathogens during infection. However, it has remained unclear whether such regulation also extends to nuclear RNA decay. Here, we show that 145 unstable nuclear RNAs, including enhancer RNAs (eRNAs) and long noncoding RNAs (lncRNAs) such as NEAT1v2, are stabilized upon Salmonella infection in HeLa cells. In uninfected cells, the RNA exosome, aided by the Nuclear EXosome Targeting (NEXT) complex, degrades these labile transcripts. Upon infection, the levels of the exosome/NEXT components, RRP6 and MTR4, dramatically decrease, resulting in transcript stabilization. Depletion of lncRNAs, NEAT1v2, or eRNA07573 in HeLa cells triggers increased susceptibility to Salmonella infection concomitant with the deregulated expression of a distinct class of immunity‐related genes, indicating that the accumulation of unstable nuclear RNAs contributes to antibacterial defense. Our results highlight a fundamental role for regulated degradation of nuclear RNA in the response to pathogenic infection.
bioRxiv | 2018
Toshimichi Yamada; Naoto Imamachi; Katsutoshi Imamura; Takeshi Kawamura; Masami Nagahama; Nobuyoshi Akimitsu
RNA-binding proteins (RBPs) play a pivotal role in gene expression by modulating the stability of transcripts; however, the identification of functional targets remains difficult, even for RBPs with a high specific binding ability, such as mammalian PUMILIO proteins (PUMs). To understand the role of RBPs in biological processes and diseases, we present a systematic approach to define the functional targets of an RBP and determine the stimulus that modulates RBP-mediated mRNA decay. We applied our method to investigate PUM function and identified 49 functional target mRNAs of PUM1. Moreover, in silico screening indicated that DNA damage reagents inhibit PUM1-mediated mRNA decay, thus enhancing cell viability. Finally, we applied our method to UPF1 and showed that UPF1-mediated mRNA decay was activated by rapamycin. Thus, our study establishes a systematic and un-biased strategy to identify the biological role of RBPs through the identification and analysis of transcripts directly regulated by RBPs.Summary RNA-binding proteins (RBPs) play a pivotal role in gene expression by modulating the stability of transcripts; however, the identification of degradation targets of RBPs remains difficult. Here, we identified 48 target mRNAs of human Pumilio 1 (PUM1), an evolutionally conserved RBP, by combined analysis of transcriptome-wide mRNA stabilities and the binding of mRNAs to PUM1. Here, we developed an approach to identify mRNA targets of Pumilio 1 (PUM1), an evolutionally conserved RBP. By combined analysis of transcriptome-wide mRNA stabilities and the binding of mRNAs to PUM1, we identified 48 mRNAs that both bound to PUM1 and exhibited PUM1-dependent degradation. Analysis of changes in the abundance of PUM1 and its targets in RNA-seq data indicated that DNA-damaging agents negatively regulated PUM1-mediated mRNA decay. Cells exposed to cisplatin had reduced PUM1 abundance and increased PCNA and UBE2A mRNAs, encoding proteins involved in DNA repair by translesion synthesis (TLS). Cells overexpressing PUM1 exhibited impaired DNA synthesis and TLS and increased sensitivity to the cytotoxic effect of cisplatin. Thus, our method identified targets of PUM1-mediated decay and revealed that cells respond to DNA damage by inhibiting PUM1-mediated mRNA decay to activate TLS.
Methods | 2014
Naoto Imamachi; Hidenori Tani; Rena Mizutani; Katsutoshi Imamura; Takuma Irie; Yutaka Suzuki; Nobuyoshi Akimitsu
Drug discoveries and therapeutics | 2012
Naoto Imamachi; Hidenori Tani; Nobuyoshi Akimitsu
Genome Research | 2017
Naoto Imamachi; Kazi Abdus Salam; Yutaka Suzuki; Nobuyoshi Akimitsu
Methods of Molecular Biology | 2015
Hidenori Tani; Naoto Imamachi; Rena Mizutani; Katsutoshi Imamura; Yeondae Kwon; Satoru Miyazaki; Sho Maekawa; Yutaka Suzuki; Nobuyoshi Akimitsu
Collaboration
Dive into the Naoto Imamachi's collaboration.
National Institute of Advanced Industrial Science and Technology
View shared research outputs